Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares saw strong trading volume on Tuesday . 395,106 shares changed hands during trading, an increase of 521% from the previous session’s volume of 63,579 shares.The stock last traded at $3.7326 and had previously closed at $3.7490.
Raia Drogasil Stock Down 0.5%
The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99. The business’s fifty day moving average price is $3.69 and its 200-day moving average price is $3.97.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.05. The company had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.32 billion. Raia Drogasil had a net margin of 2.97% and a return on equity of 18.20%. As a group, research analysts anticipate that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.
About Raia Drogasil
Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.
The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.
RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century.
Featured Stories
- Five stocks we like better than Raia Drogasil
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
